Jump to main content
Jump to site search

Issue 11, 2018
Previous Article Next Article

Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review

Author affiliations

Abstract

BODIPYs are photosensitizers activatable by light to generate highly reactive singlet oxygen (1O2) from molecular oxygen, leading to tissue damage in the photoirradiated region. Despite their extraordinary photophysical characteristics, they are not featured in clinical photodynamic therapy. This review discusses the recent advances in the design and/or modifications of BODIPYs since 2013, to improve their potential in photodynamic cancer therapy and related areas.

Graphical abstract: Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review

Back to tab navigation

Article information


Submitted
18 Mar 2018
Accepted
11 May 2018
First published
14 May 2018

Photochem. Photobiol. Sci., 2018,17, 1691-1708
Article type
Perspective

Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review

C. S. Kue, S. Y. Ng, S. H. Voon, A. Kamkaew, L. Y. Chung, L. V. Kiew and H. B. Lee, Photochem. Photobiol. Sci., 2018, 17, 1691
DOI: 10.1039/C8PP00113H

Social activity

Search articles by author

Spotlight

Advertisements